Metraipolis › archive › dc_8ea79d20ea04

Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury — Europe PMC PMID:41245486

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41245486
DOI: 10.1016/j.omtn.2025.102747
License (as archived): solo-consultazione
Archived: 2026-11-09T05:22:01.434Z
SHA-256 of the archived text: da1cf765f6a0e0d611df54460ff48b6e2b9288f53a3fc116b69ebcbd58bed385
Stable URL of this page: https://metraipolis.com/documento/dc_8ea79d20ea04

How to cite

Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury — Europe PMC PMID:41245486 — Europe PMC (en), https://europepmc.org/article/MED/41245486 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ea79d20ea04 (Metraipolis archive dc_8ea79d20ea04, sha256 da1cf765f6a0e0d611df54460ff48b6e2b9288f53a3fc116b69ebcbd58bed385)

BibTeX

@misc{dc8ea79d20ea04,
  title = {Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury — Europe PMC PMID:41245486},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41245486},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ea79d20ea04; sha256 da1cf765f6a0e0d611df54460ff48b6e2b9288f53a3fc116b69ebcbd58bed385},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41245486. Agents can read the archived copy with the MCP tool read_document.